Skip to main content
logo
Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
7.52
-0.25 (-3.22%)
Oct 16, 2026, 4:00 PM EDT - Market closed

Q32 Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
53.7453.74--6.656.65-
Revenue Growth
------
Gross Profit
39.3934.58-48.14-38.38-29.16-29.93
Operating Income
21.4616.9-66.1-48.26-39.23-36.69
Net Income
33.7929.82-47.73-53.74-42.81-37.56
Earnings Per Share
2.272.42-6.58-153.96-6.09-5.81
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
106.2748.377.9725.6243.8932.25
Total Debt
5.315.3418.950.8444.734.97
Net Cash (Debt)
100.9732.9559.06-25.22-0.8427.28
Net Cash Growth
179.44%-44.21%----
Net Cash Per Share
6.802.686.12-72.26-0.124.21

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.83-33.54-67.72-18.68-10.96-32.98
Capital Expenditures
---0.08-0.01-2.49-0.16
Free Cash Flow
-19.83-33.54-67.79-18.68-13.44-33.14
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
73.30%64.35%----
Operating Margin
39.94%31.45%---589.76%-
Pretax Margin
62.87%55.49%-803.26%-642.72%-
Profit Margin
62.87%55.49%---643.65%-
FCF Margin
-36.90%-62.42%---202.10%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
3.311.37----
PS Ratio
4.170.76----